July 9th, 2000 - 02:00 GMT Eropean CPMP gives positive opinion on Glaxo Wellcome’s new treatment for HIV, Agenerase Glaxo Wellcome plc announces that the European Union's Committee for Proprietary Medicinal Products (CPMP) has recommended the approval of Agenerase (amprenavir), Glaxo Wellcome's first protease inhib Read more
